Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global CAR-T r/r CLL Market Forecast to 2030 - Research and Markets

Research and Markets
Posted on: 05 Oct 17

The "CAR-T r/r CLL Global Market Forecast" report has been added to Research and Markets' offering.

Novel immune-therapeutic approaches in development for CLL includemonoclonal antibodies, bi-specific antibodies, anti-PD1/PDL-1 checkpoint inhibitors, and the CAR-T cell therapies including JCAR014/JCAR017 (Juno Therapeutics), KTE-C19 (Kite Pharma), and CTL019 (tisagenlecluecel-T)(Novartis Pharmaceuticals). These potential CAR-T therapies or their next generations e.g. armoured' CARs and humanized versions are in development.

This product consists of a detailed Executive presentation (~130 slides, .pdf) and MS-Excel workbook forecasting the commercial potential ($ 000s) of novel CAR-T therapies in r/r CLL across 9 major Western markets to 2030.

A patient based flow methodology has been devised where possible intervention scenarios for CAR-T introduction are visualised so that the optimum product positioning can be assessed. In addition, an up-to-date review of CLL disease background, epidemiology, current and future treatments is presented along with a comprehensive review of the CAR-T CLL competitive landscape. Pricing, cost effectiveness, manufacturing and logistical considerations are also discussed. All assumptions are clearly provided.

Key Topics Covered:

1. Executive Summary

2. Car-T Treatment For R/R Cll - Commercial Model: Key Outputs

3. Chronic Lymphocytic Leukaemia - Disease Background

4. Chronic Lymphocytic Leukaemia - Epidemiology

5. Chronic Lymphocytic Leukaemia - Treatment

6. Novel Treatments For Cll - Immunotherapy Approaches

7. Novel Treatments For Cll - Modelling Commercial Potential Of Car-T Cell Therapies

8. Bibliography

Companies Mentioned

  • Axi-Cel
  • Juno Therapeutics Inc.
  • Kite Pharma/Gilead
  • Novartis

For more information about this report visit https://www.researchandmarkets.com/research/dwstnz/cart_rr_cll

View source version on businesswire.com: http://www.businesswire.com/news/home/20171005006127/en/

Business Wire
www.businesswire.com

Last updated on: 05/10/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.